Skip to main content
. 2021 Jan 14;10(2):e018371. doi: 10.1161/JAHA.120.018371

Figure 2. Predictors of ventricular tachycardia (VT) recurrences and sustained VT/implantable cardioverter–defibrillator (ICD) shocks after the index VT ablation.

Figure 2

Preprocedural characteristics associated with (A) VT recurrence (anti‐tachycardia pacing and sustained VT/ICD shocks) and (B) sustained VT/ICD shocks alone after VT ablation in the overall population using the competing risk models are shown. AAD indicates antiarrhythmic drug; ICD, implantable cardioverter–defibrillator; LVEF, left ventricular ejection fraction, NICM, nonischemic cardiomyopathy; NYHA, New York Heart Association; and OHT, orthotopic heart transplantation.